Collective forecast

Synthesized
12%

Very Unlikely

Lives to 20012%
Does not live to 20088%
Confidencemedium· ▼ news bearish

2 markets analyzed, but news signals conflict with market pricing — treat with caution.

Based on 2 prediction markets

90% range 1213% · tight market consensus

The market probabilities suggest a higher likelihood of not reaching 200 years, which aligns with the prevailing scientific skepticism about extreme longevity.

Forecast update

Updated 17d ago

First reading — check back to watch how this forecast moves.

Why this forecast

The markets indicate a low probability of living to 200 years old, with the highest market at 12.5% for reaching that age. This aligns with current scientific understanding and societal views on longevity, which suggest significant challenges in achieving such an age.

Statistically pooled from 2 matched markets (log-odds weighted by volume), 90% CI 12-12%.

Key development

Recent studies emphasize the difficulty of living to 100, let alone 200, highlighting the challenges faced by centenarians.

Supporting signals

  • Studies show that living to 100 is already a significant challenge, indicating that 200 is even more unlikely.
  • Biohacking attempts to extend life have resulted in serious health issues, suggesting risks associated with extreme longevity.

Risk factors

  • Breakthroughs in medical science could change the landscape of longevity.
  • Societal and ethical considerations may limit the pursuit of extreme longevity.

This forecast assumes

  • Current medical advancements do not significantly extend human lifespan beyond current limits.
  • Societal attitudes towards aging and longevity remain skeptical.

Explore

Run the simulation

Replay this forecast 1,000 times, drawing from its own uncertainty band each time — watch how often lives to 200 actually happens.

Build a scenario

Toggle the assumptions this forecast depends on, stack as many as you like, and run them together.

Current medical advancements do not significantly extend human lifespan beyond current limits.
Societal attitudes towards aging and longevity remain skeptical.